How to use this page: The left column summarizes common bottlenecks (“The Problem”). The right column highlights potential advances (“The Solution”). Click any card to expand details.
The Problem
Clinical workflow + patient burden issues that slow progress.
Medical formulas have not evolved fast enough
Many formulations have not changed substantially since the 1970s.
Click to expand • Evidence note inside
Medical formulas have not evolved fast enough
Many formulations have not changed substantially since the 1970s.
Click to expand • Evidence note inside
🔎 Re-examine protein source, composition, and “delivery”
The review calls for re-assessing the nature of protein sources and formulation design to improve long-term outcomes and reduce patient burden.
Practical angle: update macronutrient profiles, consider microbiome-informed strategies, and improve usability/palatability without compromising metabolic control.
DBS monitoring delays clinical action
Posted DBS sampling commonly results in a 3–5 day turnaround.
Click to expand • Stability note inside
DBS monitoring delays clinical action
Posted DBS sampling commonly results in a 3–5 day turnaround.
Click to expand • Stability note inside
📦 Transport conditions can bias results
Sampling variability and analyte instability (temperature/humidity) can reduce timeliness and may affect accuracy.
Communication upgrade: track “time from sample → decision” as a system metric, not only a lab metric.
Long-term effects of restrictive diets are not fully mapped
Gut, hormones, and cellular signalling impacts remain incompletely characterised.
Click to expand • Research direction inside
Long-term effects of restrictive diets are not fully mapped
Gut, hormones, and cellular signalling impacts remain incompletely characterised.
Click to expand • Research direction inside
🧪 Need longitudinal assessment + omics tools
The review points to proteomics/metabolomics as future tools to understand acute vs chronic biological effects and guide safer innovation in diet therapy.
UX idea: add a small “unknowns” badge to distinguish evidence-backed items from research frontiers.
Adiposity risk requires better tracking than BMI alone
Waist circumference and/or direct fat measures are recommended alongside labs.
Click to expand • Monitoring note inside
Adiposity risk requires better tracking than BMI alone
Waist circumference and/or direct fat measures are recommended alongside labs.
Click to expand • Monitoring note inside
📏 Adiposity ≠ BMI: monitor distribution and function
Broader anthropometry and cardiometabolic markers help distinguish excess adiposity from clinical obesity and reduce long-term risk.
Visual idea: show a compact “monitoring set” row (BMI + waist + body comp + lipids/glucose) in expanded view.
The Solution
Innovation themes that could reduce burden and improve outcomes.
Precision fermentation & enzyme engineering
New functional protein substitutes and better digestibility may be achievable.
Click to expand • Safety note inside
Precision fermentation & enzyme engineering
New functional protein substitutes and better digestibility may be achievable.
Click to expand • Safety note inside
🧯 Innovation must be paired with safety evaluation
The review discusses improved substitute quality/functionality while stressing risk assessment, especially for engineered proteins.
Design option: in expanded view, show “benefit ↔ risk” as two compact bullet columns.
Plant protein & mycoprotein: renewed potential
More physiological amino acid kinetics may support muscle protein synthesis.
Click to expand • Scoring note inside
Plant protein & mycoprotein: renewed potential
More physiological amino acid kinetics may support muscle protein synthesis.
Click to expand • Scoring note inside
📚 Protein quality metrics are still evolving
The review contrasts PDCAAS/DIAAS limitations and calls for improved methods to compare proteins across processing and digestibility differences.
Optional: add a tiny glossary chip for PDCAAS / DIAAS in expanded view.
AI-enabled personalised nutrition
Combine multidimensional data to predict tolerance and guide recommendations.
Click to expand • Data → model → recommendation
AI-enabled personalised nutrition
Combine multidimensional data to predict tolerance and guide recommendations.
Click to expand • Data → model → recommendation
🧩 Data → AI model → recommendation
Integrating diet logs, biomarkers, anthropometry, genomics and microbiome signals can produce actionable, clinically validated dietary guidance.
Data
Diet logs • biomarkers • anthropometry • genotype • microbiome • activity
AI model
Pattern learning • prediction • risk flags • scenario testing
Recommendation
Personal targets • meal guidance • alerts • clinician summaries
UX option: keep recommendations patient-facing, and show rationale/uncertainty clinician-facing.
Adjunct drug therapies + dietary re-education
Greater tolerance can improve QoL but requires staged reintroduction and monitoring.
Click to expand • Weight-gain risk note inside
Adjunct drug therapies + dietary re-education
Greater tolerance can improve QoL but requires staged reintroduction and monitoring.
Click to expand • Weight-gain risk note inside
🛡️ Diet relaxation can increase weight-gain risk if unmanaged
The review stresses structured protocols for reintroducing natural protein, maintaining micronutrient adequacy, and preventing adoption of high-energy, low-quality patterns.
Visual improvement: show “increase natural protein ↔ reduce substitute” as a paired slider concept.
Point-of-Care Testing (POCT): faster feedback for PKU
POCT can shorten the time between sampling and action, enabling faster adjustments and reducing uncertainty compared with posted DBS samples.
How to read the bars
Bars represent time-to-result (minutes) using a classic scale:
longer bar = more minutes (slower), shorter bar = fewer minutes (faster).
Speed comparison only (not accuracy or clinical performance).
Short bar ≈ 2–3 min
Long bar ≈ 29–30 min
Egoo Home
Enzymatic assay + bioluminescent detection
29 min
Egoo Home
Enzymatic assay + bioluminescent detection
29 min
Portable instrument; capsule-based reagents; app-linked result display (as described in the review).
Allworth Diagnostics
Proprietary enzyme tech + advanced optics (strip-based)
2 min
Allworth Diagnostics
Proprietary enzyme tech + advanced optics (strip-based)
2 min
Handheld meter + single-use test strip; fast readout suited to frequent checks.
Apatek HomeCheck
Aptamer binding assay to quantify Phe
30 min
Apatek HomeCheck
Aptamer binding assay to quantify Phe
30 min
Cartridge + detection strip + tabletop reader; results sent to mobile app.
In Vitro Diagnostic Solutions
Test strip + reflectance meter + smartphone app
3 min
In Vitro Diagnostic Solutions
Test strip + reflectance meter + smartphone app
3 min
Capillary sample to strip; reflectance-based readout; app-linked result retrieval.
Why it matters: Faster results can enable quicker dietary/therapeutic adjustments, support illness-triggered “emergency” checks, and improve confidence and adherence through immediate feedback.